3
H index
0
i10 index
15
Citations
Eline Aas : Citation Profile
Universitetet i Oslo (50% share) | RESEARCH PRODUCTION: 13 Articles 5 Papers 3 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
15 years (2009 - 2024). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Eline Aas. | Is cited by:
| Cites to:
|
Main data
Where Eline Aas has published?
| Journals with more than one article published | # docs |
|---|---|
| The European Journal of Health Economics | 5 |
| Medical Decision Making | 3 |
| Health Economics | 2 |
| PharmacoEconomics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| HERO Online Working Paper Series / University of Oslo, Health Economics Research Programme | 5 |
Recent works citing Eline Aas (2025 and 2024)
Year  | Title of citing document |
|---|---|
| 2024 | Calculating the Expected Net Benefit of Sampling for Survival Data: A Tutorial and Case Study. (2024). Vervaart, Mathyn. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:7:p:719-741. Full description at Econpapers || Download paper |
Works by Eline Aas:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2017 | The Effect of Education on Health Behavior after Screening for Colorectal Cancer In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 0 |
| In: . [Full Text][Citation analysis] | chapter | 0 | |
| 2009 | Bruk av paneldatametoder til å belyse allmennlegers henvisningsmønster In: HERO Online Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2009 | Pecuniary compensation increases the participation rate in screening for colorectal cancer In: HERO Online Working Paper Series. [Full Text][Citation analysis] | paper | 4 |
| 2009 | The effect of screening on treatment cost: The case of colorectal cancer In: HERO Online Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2009 | Cost-effectiveness of screening for colorectal cancer with once-only flexible sigmoidoscopy and faecal occult blood test In: HERO Online Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2022 | Health Technology Assessment (HTA) of GLP-1 receptor agonists and SGLT-2 inhibitors in combination with metformin as first-line treatment in patient with type 2 diabetes mellitus (T2DM) and established cardiovascular or chronic kidney disease In: HERO Online Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2015 | Modeling and Validating the Cost and Clinical Pathway of Colorectal Cancer In: Medical Decision Making. [Full Text][Citation analysis] | article | 0 |
| 2022 | An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial In: Medical Decision Making. [Full Text][Citation analysis] | article | 1 |
| 2023 | General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations In: Medical Decision Making. [Full Text][Citation analysis] | article | 1 |
| 2021 | Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015 In: Drug Safety. [Full Text][Citation analysis] | article | 0 |
| 2016 | Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2017 | Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2017 | Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2020 | A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2020 | Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2024 | A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2024 | Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2009 | Pecuniary compensation increases participation in screening for colorectal cancer In: Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2015 | Comparative Analysis of Treatment Costs in EUROHOPE In: Health Economics. [Full Text][Citation analysis] | article | 5 |
| 2014 | Chapter 10: Policy Implications In: World Scientific Book Chapters. [Full Text][Citation analysis] | chapter | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team